← Eichor
Condition: Immune Checkpoint Inhibitor Related Colitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Checkpoint Inhibitor Related Colitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Imm
Phase 2 · 9 location(s) · University of Minnesota · NCT05726396Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Phase 2 · 2 location(s) · Shilpa Grover, MD, MPH · NCT06841705Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06807593
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.